Patents by Inventor Steve Harr

Steve Harr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230293581
    Abstract: Disclosed herein are hypoimmunogenic cells for administering to a sensitized patient. In some instances, the patient is sensitized from a previous pregnancy or a previous transplant. In some embodiments, the cells exogenously express CD47 proteins and exhibit reduced expression of MHC class I proteins, MHC class II proteins, or both.
    Type: Application
    Filed: August 12, 2021
    Publication date: September 21, 2023
    Inventors: Sonja Schrepfer, Steve Harr, Charles E. Murry
  • Publication number: 20230025289
    Abstract: Disclosed herein are cells including cells expressing CD24 and related methods of their use and generation. In some embodiments, the cells disclosed herein do not express one or more MHC I and/or MHC II human leukocyte antigens. In some embodiments, the cells are hypoimmunogenic.
    Type: Application
    Filed: August 24, 2020
    Publication date: January 26, 2023
    Inventors: Sonja SCHREPFER, Steve HARR
  • Publication number: 20220049226
    Abstract: Disclosed herein are hypoimmunogenic cells for administering to a sensitized patient. In some instances, the patient is sensitized from a previous pregnancy or a previous transplant. In some embodiments, the cells exogenously express CD47 proteins and exhibit reduced expression of MHC class I proteins, MHC class II proteins, or both.
    Type: Application
    Filed: August 12, 2021
    Publication date: February 17, 2022
    Inventors: Sonja Schrepfer, Steve Harr, Charles E. Murry